Pregled bibliografske jedinice broj: 713785
The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases
The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases // Future medicinal chemistry, 6 (2014), 6; 657-674 doi:10.4155/fmc.14.14 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 713785 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases
Autori
Eraković Haber, Vesna ; Bosnar, Martina ; Kragol, Goran
Izvornik
Future medicinal chemistry (1756-8919) 6
(2014), 6;
657-674
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Macrolide; anti-inflammatory activity; azithromycin
Sažetak
Neutrophil-dominated inflammatory diseases, like chronic obstructive pulmonary disease, cystic fibrosis, bronchiectasis, bronchiolitis obliteras syndrome and non-eosinophilic asthma, present a significant medical problem lacking adequate therapy. Macrolide antibiotics have been reported to be effective in the treatment of the aforementioned diseases, for reasons unrelated to their antibacterial action. This has resulted in research activities aimed at gaining a better understanding of the immunomodulatory actions of macrolides and the synthesis of various novel anti-inflammatory macrolides without antimicrobial activity. Despite the difficult chemistry and lack of an extensive knowledge for their mechanism of action, several interesting molecules from this class, including potential clinical candidates, are on the horizon.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Fidelta d.o.o.
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE